Abiopharma

LifeMD Appoints Umesh Sripad as Chief Technology Officer

Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting

Imfinzi plus Imjudo combined with lenvatinib and TACE reduced the risk of disease progression or death in EMERALD-3 Phase III trial

Net Asset Value(s)

Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development

Amneal Pharmaceuticals, Inc. - Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

Waters - Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters - Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Spectral AI Announces Voting Results of Annual Meeting of Stockholders